Nidan Laboratories and Healthcare Limited IPO
Nidan Laboratories and Healthcare Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹125 per share. The stock debuted at ₹123.9. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹1,25,000.
Nidan Laboratories and Healthcare Limited IPO
- IPO Dates
- Oct 28, 2021 – Nov 2, 2021
- Price band
- ₹125 per equity share
- Minimum Investment
- ₹1,25,000
- Issue size
- 4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Cr)
- Lot size
- 1000
- Allotment Date
- Nov 10, 2021
- Listing
- Nov 12, 2021
- Listing At
- NSE SME
IPO timeline
-
Oct 28, 2021
Open Date
Completed
-
Nov 2, 2021
Close Date
Completed
-
Nov 10, 2021
Allotment Date
Completed
-
Nov 12, 2021
Listing Date
Completed
Nidan Laboratories and Healthcare Limited IPO Essentials
Nidan Laboratories and Healthcare Limited IPO Details
Nidan Laboratories and Healthcare Limited IPO is priced at ₹125 per share with a total issue size of 4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Cr). The IPO has a lot size of 1000 shares and is listed on NSE SME.
- Issue price
- ₹125 per equity share
- Lot size
- 1000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Cr)
- Listing at
- NSE SME
- List price
- 123.90
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
First Overseas Capital Limited
Nidan Laboratories and Healthcare Limited IPO Details
- Retail Portion N/A
Nidan Laboratories and Healthcare Limited IPO Documents
Nidan Laboratories and Healthcare Limited IPO Analytics
Nidan Laboratories and Healthcare Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Nidan Laboratories and Healthcare Limited IPO Subscription Status
Nidan Laboratories and Healthcare Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 19,00,000 | 19,00,000 | 38,00,000 |
|
Day 1
28-10-21 06:00 PM
|
(0.01) x | 1.13 x | 0.57 x |
|
Day 2
29-10-21 06:00 PM
|
(0.02) x | 1.81 x | 0.91 x |
|
Day 3
01-11-21 06:00 PM
|
(0.14) x | 2.74 x | 1.44 x |
|
Day 4
02-11-21 06:00 PM
|
(0.15) x | 3.44 x | 1.80 x |
Nidan Laboratories and Healthcare Limited Valuations
Earnings
- EPS (Post IPO)
- ₹1.66/-
- P/E Ratio
- 75.48
Returns
- RoNW
- 0.17%
Nidan Laboratories and Healthcare Limited Financials( In Crs.)
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
|---|---|---|---|
| Assets | 52.43 | 45.20 | 43.05 |
| Revenue | 21.85 | 22.19 | 20.97 |
| Profit After Tax | 2.30 | 0.71 | 0.22 |
Nidan Laboratories and Healthcare Limited Company & Offer Insights
About Nidan Laboratories and Healthcare Limited
Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.
Nidan Laboratories and Healthcare Limited Promoter(s)
Dr. Nithin Vitthalrao Thorave are the company's promoters of Nidan Laboratories and Healthcare Limited.
Nidan Laboratories and Healthcare Limited IPO Issue Objectives
- •
- Repayment of loans – Rs.16 crores.
- •
- Additional Working Capital – Rs.26 crores.
- •
- General Corporate Expenses – Rs.4.4 crores.
- •
- To meet the expenses of the Issue – Rs.3.6 crores.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Nidan Laboratories and Healthcare Limited IPO is a Fixed Priced IPO worth ₹4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Cr). The issue price is ₹125 per share (fixed price). The IPO opens on Oct 28, 2021 and closes on Nov 2, 2021. It will be listed on NSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The issue price of Nidan Laboratories and Healthcare Limited IPO is ₹125 per share (fixed price).
The lot size of Nidan Laboratories and Healthcare Limited IPO is 1000 shares.
The minimum investment for Nidan Laboratories and Healthcare Limited IPO is approximately ₹1,25,000 based on the issue price .
Nidan Laboratories and Healthcare Limited IPO opens on Oct 28, 2021 and closes on Nov 2, 2021.
The allotment date of Nidan Laboratories and Healthcare Limited IPO is Nov 10, 2021.
Nidan Laboratories and Healthcare Limited IPO is expected to be listed on Nov 12, 2021, on NSE SME Platform.
Nidan Laboratories and Healthcare Limited IPO valuation snapshot: P/E 75.48, EPS ₹1.66/-, P/B N/A, RoNW 0.17%, and market cap N/A.
To apply for Nidan Laboratories and Healthcare Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Nidan Laboratories and Healthcare Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Nidan Laboratories and Healthcare Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Nidan Laboratories and Healthcare Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Nidan Laboratories and Healthcare Limited IPO allotment status on IPO Ji for quick and easy access.